GM Salmon and Wild Fish Can Reproduce

Genetically modified Atlantic salmon, which could soon become the first transgenic animal sold as food in the U.S., can breed with wild brown trout to produce a GM hybrid.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Atlantic slamon (Salmo salar)WIKIMEDIA, TIMOTHY KNEPP, U.S. FISH AND WILDLIFE SERVICETransgenic Atlantic salmon, genetically modified to grow larger and faster than wild-type fish, are capable of hybridizing with wild brown trout, creating offspring that carry modified growth genes and outcompete both wild and GM fish, according to new research conducted by Canadian scientists. The modified salmon is poised to become the first GM animal approved for human consumption in the United States, with the US Food and Drug Administration approaching a decision on the product.

“We suggest that interspecific hybridization be explicitly considered when assessing the environmental consequences should transgenic animals escape to nature,” wrote the authors of a paper announcing the results in the current issue of Proceedings of the Royal Society B.

AquaBounty, the biotech company that makes the GM salmon (dubbed AquAdvantage), countered that their product consists of female, sterile fish that would be reared in aquaculture facilities on land, making any such risks negligible. “Overall, the study seems to present no new evidence for any added environmental risk associated with the AquAdvantage salmon,” AquaBounty CEO Ron Stotish told BBC News.

Testing whether the propensity for wild Atlantic salmon to hybridize with wild brown trout—both members of the genus Salmo—researchers from the Memorial University of Newfoundland, Canada, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies